Documentation Pain Management Groups Typically Request First
Because pain medicine and physical medicine practices often work across multiple referring physicians, a documentation request for a new biologics vendor is frequently initiated by whichever physician in the group intends to be the ordering account holder.
Precision Biologics provides a certificate of analysis, donor eligibility summary and lot release record to verified accounts, along with the supplier's characterization data for exosome products, including ELISA, nanoparticle tracking analysis and SP-IRIS results reported for Bio Xsomes.
Buffalo
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
60- Pain Medicine
- 26
- Physical Medicine & Rehabilitation
- 34
Account Verification Through NPI
Every Precision Biologics account is tied to a National Provider Identifier that is checked against the NPPES registry before the account is approved.
In a multi-physician pain management group, this generally means one physician serves as the verified account holder even when several providers in the group may be involved in evaluating a vendor.
Delivery and Storage for Northeast Practices
Cryopreserved formats are shipped overnight on dry ice in validated containers and arrive requiring immediate transfer to -80 degree Celsius storage; practices should confirm receiving coverage on the expected delivery day, particularly around winter weather disruptions common to carrier schedules in the Northeast.
Lyophilized exosome and Wharton's jelly formats are shelf-stable and do not require cryogenic equipment, which some practices prefer for simplified receiving.
Regulatory Verification and What Precision Biologics Does Not Provide
Precision Biologics is not positioned to tell a pain management practice how a given product fits its own regulatory posture; that assessment, with reference to 21 CFR 1271.10 and section 351 biologic drug regulation for exosome products, belongs to the practice and its counsel, and licensure should be confirmed directly with the New York State Board for Medicine or the applicable physical medicine licensing board.
Precision Biologics support is limited to NPI verification, documentation requests and arranging a physician-level call to walk through paperwork, not clinical or procedural guidance.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Are Bio Xsomes or other exosome products FDA approved for use by pain management practices in Buffalo?+
No. FDA has stated there are no FDA-approved exosome products, and these products are generally regulated as biologic drugs. Purchase and clinical use decisions remain with the physician and the practice's own regulatory counsel.
Does a pain management group need a separate account from an affiliated physical medicine practice?+
Accounts are tied to a verified NPI rather than a practice name, so affiliated pain medicine and physical medicine providers under the same group may need separate verified accounts depending on how each is structured.
What should a Buffalo practice check before placing a first order?+
Confirm licensure directly with the New York State Board for Medicine or relevant board, and have practice counsel review how the intended use is classified under 21 CFR 1271.10 before requesting documentation or placing an order.